Surgical Options for Recurrence in Hidradenitis Suppurativa
No, surgical intervention with flap surgery is not the only option for recurrence in hidradenitis suppurativa, though it offers among the lowest recurrence rates for extensive disease. Multiple surgical and non-surgical approaches can be used for recurrent disease, with the choice depending on disease severity, location, and extent.
Surgical Treatment Options for Recurrent Disease
Wide Excision Options
- Radical wide excision: Offers lower recurrence rates (2.5-27%) compared to limited excision (42.8%) or drainage procedures (100%) 1
- Reconstruction methods after excision:
Less Invasive Surgical Options
- Deroofing procedure: 83% showed no recurrence during median follow-up of 34 months 1
- STEEP (Skin-Tissue-Saving Excision with Electrosurgical Peeling): 29.2% recurrence rate over 43 months 1
- CO2 laser excision: Recurrence rates as low as 1.1% in some studies, but variable results (11.8-29%) in others 1
Non-Surgical Options for Recurrent Disease
Medical Therapies
Adalimumab: FDA-approved for moderate to severe HS at 40mg weekly dosing (not every other week) 4
Antibiotics:
Other Interventions
- Intralesional corticosteroid injections: For carefully selected individual lesions during acute phase 1
- Acitretin: Consider in males and non-fertile females unresponsive to antibiotics 1
Treatment Algorithm Based on Disease Severity and Recurrence Pattern
For Limited Recurrence (Few Isolated Lesions)
- First-line: Deroofing procedure or limited excision
- Alternative: Intralesional corticosteroid injections for acute flares
- For persistent lesions: CO2 laser excision
For Extensive Recurrence
First-line: Radical wide excision with appropriate reconstruction
- Flap reconstruction for axillary, groin, or perineal areas
- Split-thickness skin grafts for larger areas
- Secondary intention healing for areas where cosmetic outcome is less critical
Medical adjuncts:
- Adalimumab (weekly dosing) for moderate-to-severe disease
- Clindamycin/rifampicin combination for less severe cases
Factors Affecting Surgical Outcomes
- Location: Perianal, perineal, and buttocks areas have higher complication rates (25%) 6
- Age: Younger patients have higher recurrence risk (HR 0.8) 7
- Multiple surgical sites: Increases recurrence risk (HR 1.6) 7
- Procedure type: Drainage procedures have highest recurrence risk (HR 3.5) 7
- Width of excision: More important than closure technique for preventing recurrence 1
Important Considerations
- Recurrence should be viewed as a feature of the disease rather than a failure of treatment 8
- Patients may require multiple procedures over time to maintain symptom control 8
- The British Association of Dermatologists recommends extensive excision when conventional systemic treatments have failed 1
- For axillary recurrence specifically, the Limberg transposition flap shows excellent functional and aesthetic results with low recurrence 3
Pitfalls to Avoid
- Avoid simple incision and drainage for recurrent disease as it has nearly 100% recurrence rate 1
- Avoid primary closure alone for extensive disease (69.9% recurrence) 2
- Don't underestimate the extent of disease: Ensure complete removal of all affected tissue to reduce recurrence
- Don't overlook medical therapy as an adjunct to surgical management or for patients who are poor surgical candidates
In summary, while flap surgery offers excellent outcomes for recurrent hidradenitis suppurativa, multiple other surgical and medical options exist. The choice should be based on disease extent, location, and previous treatments, with radical excision (with appropriate reconstruction) offering the lowest recurrence rates for extensive disease.